Community Academic Profiles–

Sarah S. Donaldson, M.D.

Back to Profile

Publication Details

  • Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG.

    Donaldson SS, Meza J, Breneman JC, Crist WM, Laurie F, Qualman SJ, Wharam M. Int J Radiat Oncol Biol Phys. 2001; 51 (3): 718-28

    To evaluate the outcome and toxicity of hyperfractionated radiotherapy (HFRT) vs. conventionally fractionated radiotherapy (CFRT) in children with Group III rhabdomyosarcoma (RMS).

    PubMedID: 11597814

Stanford Medicine Resources:

Footer Links: